JP2022174207A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022174207A5 JP2022174207A5 JP2022143550A JP2022143550A JP2022174207A5 JP 2022174207 A5 JP2022174207 A5 JP 2022174207A5 JP 2022143550 A JP2022143550 A JP 2022143550A JP 2022143550 A JP2022143550 A JP 2022143550A JP 2022174207 A5 JP2022174207 A5 JP 2022174207A5
- Authority
- JP
- Japan
- Prior art keywords
- gene
- stat1
- ch25h
- disease
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762506782P | 2017-05-16 | 2017-05-16 | |
| US62/506,782 | 2017-05-16 | ||
| PCT/US2018/031901 WO2018213081A1 (en) | 2017-05-16 | 2018-05-09 | Compositions and methods for treating alzheimer's disease |
| JP2019563786A JP7675502B2 (ja) | 2017-05-16 | 2018-05-09 | アルツハイマー病の治療用組成物および治療方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019563786A Division JP7675502B2 (ja) | 2017-05-16 | 2018-05-09 | アルツハイマー病の治療用組成物および治療方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022174207A JP2022174207A (ja) | 2022-11-22 |
| JP2022174207A5 true JP2022174207A5 (https=) | 2023-03-27 |
Family
ID=64274628
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019563786A Active JP7675502B2 (ja) | 2017-05-16 | 2018-05-09 | アルツハイマー病の治療用組成物および治療方法 |
| JP2022143550A Pending JP2022174207A (ja) | 2017-05-16 | 2022-09-09 | アルツハイマー病の治療用組成物および治療方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019563786A Active JP7675502B2 (ja) | 2017-05-16 | 2018-05-09 | アルツハイマー病の治療用組成物および治療方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11873321B2 (https=) |
| EP (1) | EP3628008A4 (https=) |
| JP (2) | JP7675502B2 (https=) |
| KR (1) | KR20200010311A (https=) |
| CN (2) | CN119488598A (https=) |
| AU (1) | AU2018270906B2 (https=) |
| CA (1) | CA3063217A1 (https=) |
| TW (1) | TW201900216A (https=) |
| WO (1) | WO2018213081A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018213081A1 (en) * | 2017-05-16 | 2018-11-22 | Generos Biopharma Ltd. | Compositions and methods for treating alzheimer's disease |
| CN111500694B (zh) * | 2019-01-31 | 2023-02-24 | 中国科学院脑科学与智能技术卓越创新中心 | Baz2b基因作为靶点在缓解衰老中的应用 |
| MX2022012252A (es) * | 2020-03-31 | 2023-03-08 | Wilfred Jefferies | Metodos para tratar la enfermedad de alzheimer. |
| WO2023244611A1 (en) * | 2022-06-13 | 2023-12-21 | Emory University | Uses of jak inhibitors in the management of inflammation-associated depression and central nervous system (cns) pathologies |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7285526B2 (en) * | 1995-07-14 | 2007-10-23 | Meiogen Biotechnology Corporation | Interferon antagonists useful for the treatment of interferon related diseases |
| US20020188012A1 (en) * | 1998-01-28 | 2002-12-12 | Bisgaier Charles Larry | Method for treating Alzheimer's disease |
| US20060275294A1 (en) | 2002-08-22 | 2006-12-07 | Omoigui Osemwota S | Method of prevention and treatment of aging, age-related disorders and/or age-related manifestations including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimers disease and cancer |
| WO2008024919A2 (en) * | 2006-08-23 | 2008-02-28 | University Of Medicine And Dentistry Of New Jersey | Interferon antagonists, antibodies thereto, and associated methods of use |
| US9272029B2 (en) * | 2009-03-26 | 2016-03-01 | Ibc Pharmaceuticals, Inc. | Interferon lambada-antibody complexes |
| US9987224B2 (en) * | 2011-02-04 | 2018-06-05 | Joseph E. Kovarik | Method and system for preventing migraine headaches, cluster headaches and dizziness |
| EP3140403A4 (en) | 2014-05-09 | 2017-12-20 | Université Laval | Prevention and treatment of alzheimer's disease by genome editing using the crispr/cas system |
| KR102531016B1 (ko) * | 2014-11-21 | 2023-05-10 | 리제너론 파마슈티칼스 인코포레이티드 | 쌍 형성된 가이드 rna를 사용하는 표적화된 유전자 변형을 위한 방법 및 조성물 |
| WO2018213081A1 (en) * | 2017-05-16 | 2018-11-22 | Generos Biopharma Ltd. | Compositions and methods for treating alzheimer's disease |
-
2018
- 2018-05-09 WO PCT/US2018/031901 patent/WO2018213081A1/en not_active Ceased
- 2018-05-09 US US16/613,264 patent/US11873321B2/en active Active
- 2018-05-09 AU AU2018270906A patent/AU2018270906B2/en active Active
- 2018-05-09 CN CN202411664773.XA patent/CN119488598A/zh active Pending
- 2018-05-09 JP JP2019563786A patent/JP7675502B2/ja active Active
- 2018-05-09 KR KR1020197036561A patent/KR20200010311A/ko not_active Ceased
- 2018-05-09 CN CN201880045403.4A patent/CN111132694B/zh active Active
- 2018-05-09 EP EP18802949.0A patent/EP3628008A4/en active Pending
- 2018-05-09 CA CA3063217A patent/CA3063217A1/en active Pending
- 2018-05-16 TW TW107116606A patent/TW201900216A/zh unknown
-
2022
- 2022-09-09 JP JP2022143550A patent/JP2022174207A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022174207A5 (https=) | ||
| JP2024088668A5 (https=) | ||
| JP2005526107A5 (https=) | ||
| JP2021534129A5 (https=) | ||
| JP2006514689A5 (ja) | １−オキソ−２−（２，６−ジオキソピペリジン−３−イル）−４−メチルイソインドリンを含む脳腫瘍の治療及び管理のための医薬組成物 | |
| CA2530006A1 (en) | Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease | |
| JP2023076465A5 (https=) | ||
| JP2006506425A5 (https=) | ||
| DE60107820D1 (de) | Neue verwendung von phenylheteroalkylamin-derivaten | |
| JP2005509662A5 (https=) | ||
| JP2013528655A5 (https=) | ||
| TNSN05163A1 (fr) | Derives de pyrrolo-pyrazole substitues servant d'inhibiteurs de kinases | |
| CN115315423A (zh) | 取代芳基类化合物 | |
| Aufdemorte et al. | Griseofulvin in the treatment of three cases of oral erosive lichen planus | |
| JPH05163139A (ja) | 抗動脈硬化剤 | |
| MA46268B1 (fr) | Dérivés de 5-[2-(pyridin-2-ylamino)-1 ,3-thiazol-5-yl]-2,3-dihydro-1h-isoindol-1-one et leur utilisation en tant qu'inhibiteurs doubles de phosphatidylinositol 3-kinase delta & gamma | |
| CA2526989A1 (en) | Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors | |
| JP2024541569A5 (https=) | ||
| JP2022510303A5 (https=) | ||
| JP2017132781A5 (https=) | ||
| JP2021512921A5 (https=) | ||
| JP2023022236A5 (https=) | ||
| JP2023509698A5 (https=) | ||
| JP2006510606A5 (https=) | ||
| JP2004502684A5 (https=) |